marketcaparena
Search

    VERU

    VERU INC.

    Company overview

    Market capitalization
    $43.05M
    Employees
    20
    Latest publication
    2026-09-29
    About VERU INC.

    Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
    Total Revenue56,386USD0USD247,064USD0USD0USD0USD6,656,522USD3,953,870USD
    Cost Of Revenue28,193USD28,193USD28,573USD29,331USD29,331USD64,870USD3,969,311USD2,615,855USD
    Gross Profit28,193USD-28,193USD-28,573USD-29,331USD-29,331USD-64,870USD2,687,211USD1,338,015USD
    Research Development3,145,783USD1,344,182USD2,918,690USD3,020,563USD3,932,102USD5,716,830USD3,292,320USD4,879,024USD
    Selling General Administrative4,073,185USD4,079,833USD13,796,030USD5,010,528USD5,164,433USD5,227,113USD7,794,717USD7,507,609USD
    Total Operating Expenses7,218,968USD5,395,822USD7,430,790USD8,001,760USD8,122,232USD10,248,727USD10,892,501USD12,276,633USD
    Operating Income-7,218,968USD-5,424,015USD-7,459,363USD-8,031,091USD-8,122,232USD-10,248,727USD-8,205,290USD-10,938,618USD
    Income Before Tax-3,092,550USD-5,332,579USD1,304,140USD-7,323,101USD-7,852,393USD-1,809,903USD-8,077,507USD-10,806,452USD
    Net Income-2,741,132USD-5,332,579USD1,303,919USD-7,332,820USD-7,901,619USD-8,945,347USD-8,530,623USD-10,968,874USD
    Net Income From Continuing Ops-3,092,550USD-5,332,579USD1,304,140USD-7,323,101USD-7,852,393USD-1,809,903USD-8,530,623USD-10,968,874USD
    Ebit-7,218,968USD-5,424,015USD-7,459,363USD-8,031,091USD-9,096,535USD-10,943,943USD-7,907,640USD-10,679,222USD
    Ebitda-7,190,774USD-5,395,822USD-7,430,790USD-8,001,760USD-9,067,204USD-10,879,073USD-7,842,496USD-10,614,118USD
    Depreciation And Amortization28,194USD28,193USD28,573USD29,331USD29,331USD64,870USD65,144USD65,104USD
    Reconciled Depreciation28,194USD28,193USD28,573USD29,331USD29,331USD64,870USD65,144USD65,104USD
    Total Other Income Expense Net4,126,418USD91,436USD8,763,503USD707,990USD269,839USD8,438,824USD127,783USD132,166USD
    Unclassified Operating Expenses——-9,283,930USD—————
    Income Tax Expense—————-7,135,444USD453,116USD162,422USD
    Interest Expense——————169,867USD127,336USD
    Net Interest Income——————-169,867USD-127,336USD
    Tax Provision——————453,116USD162,422USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20182018-09-30 · USD
    Total Revenue0USD16,886,419USD16,296,958USD39,354,352USD61,259,528USD42,592,060USD31,803,387USD15,864,483USD
    Cost Of Revenue152,105USD11,032,442USD8,731,030USD8,762,964USD13,332,305USD11,805,202USD10,146,565USD7,081,981USD
    Gross Profit-152,105USD5,853,977USD7,565,928USD30,591,388USD47,927,223USD30,786,858USD21,656,822USD8,782,502USD
    Research Development15,588,185USD12,808,185USD51,202,219USD70,646,103USD32,694,405USD16,935,222USD13,743,826USD10,850,958USD
    Selling General Administrative19,942,747USD31,184,097USD48,057,834USD43,168,845USD20,670,319USD14,498,330USD14,348,890USD14,817,433USD
    Unclassified Operating Expenses-10,780,290USD-1,222,908USD2,088,091USD——14,100,000USD—3,986,518USD
    Total Operating Expenses24,750,642USD42,769,374USD101,348,144USD113,814,948USD53,364,724USD45,533,552USD28,092,716USD29,654,909USD
    Operating Income-24,750,642USD-36,915,397USD-93,782,216USD-83,223,560USD12,972,657USD-14,746,694USD-6,435,894USD-20,872,407USD
    Income Before Tax-15,681,257USD-37,076,325USD-92,672,486USD-83,539,623USD4,265,236USD-20,051,976USD-12,321,299USD-23,072,287USD
    Net Income-22,726,279USD-37,801,426USD-93,152,692USD-83,776,020USD7,394,374USD-18,973,535USD-12,017,366USD-23,938,389USD
    Net Income From Continuing Ops-15,681,257USD-37,801,426USD-93,088,953USD-83,776,020USD7,394,374USD-18,973,535USD-12,017,366USD-23,938,389USD
    Ebit-35,530,932USD-36,468,852USD-90,245,449USD-83,223,560USD9,151,289USD-14,746,694USD-6,435,894USD-20,872,407USD
    Ebitda-35,378,827USD-36,200,675USD-89,975,575USD-83,013,965USD9,745,159USD-14,283,953USD-5,964,473USD-20,420,359USD
    Depreciation And Amortization152,105USD268,177USD269,874USD209,595USD593,870USD462,741USD471,421USD452,048USD
    Reconciled Depreciation152,105USD268,177USD269,874USD209,595USD211,394USD462,741USD471,421USD452,048USD
    Total Other Income Expense Net9,069,385USD-160,928USD1,109,730USD-316,063USD-8,707,421USD-5,305,282USD-5,885,405USD-2,199,880USD
    Interest Expense—607,470USD2,427,041USD4,368,798USD4,886,054USD4,621,422USD4,706,056USD2,950,501USD
    Net Interest Income—-607,470USD-2,427,041USD-4,368,798USD-4,886,054USD-4,621,422USD-4,706,056USD-2,950,501USD
    Income Tax Expense—725,101USD480,206USD236,397USD-3,129,138USD-1,078,441USD-303,933USD866,102USD
    Tax Provision—725,101USD480,206USD236,397USD-3,129,138USD-1,078,441USD-303,933USD866,102USD
    Non Operating Income Net Other———4,052,735USD-3,821,367USD-683,860USD-1,179,349USD750,621USD
    Net Income Applicable To Common Shares———-83,776,020USD7,394,374USD-18,973,535USD-12,017,366USD-23,938,389USD
    Interest Income——————5,885,410USD2,199,880USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
    Total Assets43,082,726USD47,567,030USD29,835,719USD27,330,758USD32,671,943USD39,828,594USD60,418,772USD64,631,654USD
    Other Current Assets2,590,923USD1,410,072USD595,251USD1,183,023USD1,359,372USD1,773,134USD2,202,455USD2,740,953USD
    Total Liab8,297,105USD10,442,989USD11,503,049USD11,986,125USD11,624,710USD13,201,605USD28,102,060USD27,011,198USD
    Total Stockholder Equity34,785,621USD37,124,041USD18,332,670USD15,344,633USD21,047,233USD26,626,989USD32,316,712USD37,620,456USD
    Other Current Liab2,546,876USD4,846,972USD3,904,766USD3,389,891USD2,665,895USD3,611,134USD6,339,793USD5,576,518USD
    Common Stock162,687USD162,687USD148,687USD148,688USD1,487,676USD1,485,676USD1,485,676USD1,485,676USD
    Capital Stock162,687USD162,687USD148,687USD148,688USD1,487,676USD1,485,676USD1,485,676USD1,485,676USD
    Retained Earnings-325,369,625USD-322,628,493USD-317,295,914USD-318,749,421USD-311,416,601USD-303,514,982USD-294,569,635USD-286,039,012USD
    Good Will6,878,932USD6,878,932USD6,878,932USD6,878,932USD6,878,932USD6,878,932USD6,878,932USD6,878,932USD
    Cash27,596,820USD32,991,417USD15,794,562USD15,010,154USD20,018,392USD26,607,002USD24,916,285USD29,150,879USD
    Cash And Short Term Investments30,764,553USD35,396,644USD18,319,867USD15,010,154USD20,018,392USD26,607,002USD24,916,285USD29,150,879USD
    Total Current Assets33,355,476USD36,806,716USD18,915,118USD16,193,177USD21,377,764USD28,380,136USD35,223,224USD38,476,141USD
    Total Current Liabilities5,388,843USD7,127,700USD7,785,160USD6,682,015USD5,619,320USD6,348,228USD11,867,968USD10,620,035USD
    Net Debt-24,763,474USD-30,014,060USD-12,677,598USD-11,756,018USD-16,629,476USD-23,089,363USD-11,052,779USD-15,473,908USD
    Short Term Debt770,257USD764,590USD758,946USD753,400USD747,951USD742,449USD2,091,334USD2,025,183USD
    Short Long Term Debt Total2,833,346USD2,977,357USD3,116,964USD3,254,136USD3,388,916USD3,517,639USD13,863,506USD13,676,971USD
    Short Term Investments3,167,733USD2,405,227USD2,525,305USD———742,295USD—
    Accounts Payable2,071,710USD1,516,138USD3,121,448USD2,538,724USD2,205,474USD1,994,645USD3,036,841USD3,018,334USD
    Property Plant Equipment Net2,787,769USD2,950,535USD3,110,822USD3,269,053USD3,425,651USD3,579,930USD4,846,427USD5,247,941USD
    Property Plant Equipment Gross3,444,791USD3,579,363USD3,711,457USD3,841,115USD3,968,382USD4,093,330USD8,865,452USD9,201,822USD
    Common Stock Shares Outstanding21,655,705shares20,311,190shares14,650,320shares14,657,777shares14,638,614shares14,638,392shares14,638,392shares14,638,316shares
    Non Current Assets Total9,727,250USD10,760,314USD10,920,601USD11,137,581USD11,294,179USD11,448,458USD25,195,548USD26,155,513USD
    Non Current Liabilities Total2,908,262USD3,315,289USD3,717,889USD5,304,110USD6,005,390USD6,853,377USD16,234,092USD16,391,163USD
    Non Current Liabilities Other845,173USD1,102,522USD1,359,871USD2,803,374USD3,364,425USD4,078,187USD4,461,920USD4,739,375USD
    Non Currrent Assets Other60,549USD930,847USD930,847USD989,596USD989,596USD989,596USD1,129,952USD1,320,328USD
    Net Working Capital27,966,633USD29,679,016USD11,129,958USD9,511,162USD15,758,444USD22,031,908USD23,355,256USD27,856,106USD
    Unclassified Non Current Liabilities2,063,089USD2,212,767USD2,358,018USD2,500,736USD2,640,965USD2,775,190USD2,921,380USD3,074,721USD
    Unclassified Equity359,829,872USD359,427,160USD335,331,210USD333,796,678USD329,488,482USD327,170,619USD324,496,514USD321,269,635USD
    Current Deferred Revenue——————400,000USD1,858,053USD
    Short Long Term Debt——————1,025,837USD986,388USD
    Long Term Debt——————8,850,792USD8,577,067USD
    Net Receivables——————3,960,305USD1,642,063USD
    Inventory——————4,144,179USD4,942,246USD
    Accumulated Other Comprehensive Income——————-581,519USD-581,519USD
    Unclassified Non Current Assets——————12,340,237USD12,479,488USD
    Unclassified Current Liabilities——————-1,025,837USD-2,844,441USD
    Long Term Investments———————228,824USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20182018-09-30 · USD
    Total Assets29,835,719USD60,418,772USD50,023,091USD135,358,450USD178,146,723USD51,543,675USD53,628,770USD48,452,639USD
    Other Current Assets595,251USD2,202,455USD2,104,103USD11,641,393USD10,025,475USD1,494,541USD1,843,297USD1,148,345USD
    Total Liab11,503,049USD28,102,060USD30,344,930USD52,561,133USD25,852,779USD21,432,359USD21,295,634USD18,971,221USD
    Total Stockholder Equity18,332,670USD32,316,712USD19,678,161USD82,797,317USD152,293,944USD30,111,316USD32,333,136USD29,481,418USD
    Other Current Liab3,904,766USD6,339,793USD2,873,347USD14,581,807USD8,490,425USD24,410,632USD17,581,575USD26,519,014USD
    Common Stock148,687USD1,485,676USD939,664USD826,926USD821,535USD720,474USD672,220USD574,687USD
    Capital Stock148,687USD1,485,676USD939,664USD826,926USD821,535USD720,474USD672,220USD574,687USD
    Retained Earnings-317,295,914USD-294,569,635USD-256,768,209USD-163,615,517USD-81,798,178USD-89,192,552USD-70,219,017USD-58,201,651USD
    Good Will6,878,932USD6,878,932USD6,878,932USD6,878,932USD6,878,932USD6,878,932USD6,878,932USD6,878,932USD
    Cash15,794,562USD24,916,285USD9,625,494USD80,190,675USD122,359,535USD13,588,778USD6,295,152USD3,759,509USD
    Cash And Short Term Investments18,319,867USD24,916,285USD9,625,494USD80,190,675USD122,359,535USD13,588,778USD6,295,152USD3,759,509USD
    Total Current Assets18,915,118USD35,223,224USD22,933,222USD104,001,907USD151,753,487USD27,014,690USD16,806,912USD11,182,516USD
    Total Current Liabilities7,785,160USD11,867,968USD17,810,732USD38,711,381USD15,767,310USD14,727,141USD14,019,975USD13,552,927USD
    Net Debt-12,677,598USD-11,052,779USD4,779,969USD-64,314,387USD-108,608,364USD547,572USD5,822,397USD7,388,584USD
    Short Term Debt758,946USD2,091,334USD1,901,213USD2,126,180USD3,735,114USD7,549,836USD5,385,649USD6,692,718USD
    Short Long Term Debt Total3,116,964USD13,863,506USD14,405,463USD15,876,288USD13,742,171USD14,136,350USD12,117,549USD11,148,093USD
    Short Term Investments2,525,305USD742,295USD—————0USD
    Accounts Payable3,121,448USD3,036,841USD12,931,172USD22,003,394USD3,409,771USD2,812,673USD3,124,751USD3,226,036USD
    Property Plant Equipment Net3,110,822USD4,846,427USD5,985,205USD5,972,681USD1,562,442USD1,665,006USD351,895USD404,552USD
    Property Plant Equipment Gross3,711,457USD8,865,452USD9,773,159USD5,972,681USD5,135,615USD1,665,006USD351,895USD404,552USD
    Common Stock Shares Outstanding14,646,294shares13,487,501shares8,497,338shares8,012,252shares8,380,242shares6,675,345shares6,332,312shares5,386,198shares
    Non Current Assets Total10,920,601USD25,195,548USD27,089,869USD31,356,543USD26,393,236USD24,528,985USD36,821,858USD37,270,123USD
    Non Current Liabilities Total3,717,889USD16,234,092USD12,534,198USD13,849,752USD10,085,469USD6,705,218USD7,275,659USD5,418,294USD
    Non Current Liabilities Other1,359,871USD4,461,920USD29,948USD13,768,685USD10,022,043USD6,630,494USD4,092,672USD30,000USD
    Non Currrent Assets Other930,847USD1,129,952USD1,512,361USD1,561,564USD2,440,944USD766,120USD988,867USD965,152USD
    Net Working Capital11,129,958USD23,355,256USD3,227,548USD63,331,845USD135,986,177USD12,287,549USD2,786,937USD-2,370,411USD
    Unclassified Non Current Liabilities2,358,018USD2,921,380USD3,634,114USD-9,756,085USD-9,475,548USD-5,707,198USD——
    Unclassified Equity335,331,210USD324,496,514USD275,148,561USD253,147,106USD240,837,176USD126,251,044USD109,595,837USD94,921,819USD
    Intangible Assets—5,952USD5,952USD3,977,381USD4,048,810USD5,752,127USD20,168,495USD20,477,729USD
    Other Assets—451,159USD—14,527,549USD13,903,052USD10,232,920USD9,422,536USD9,508,910USD
    Current Deferred Revenue—400,000USD105,000USD342,000USD132,000USD6,000USD249,000USD202,452USD
    Short Long Term Debt—1,025,837USD864,623USD1,169,095USD3,237,211USD5,841,874USD5,385,649USD6,692,718USD
    Long Term Debt—8,850,792USD8,870,136USD9,656,441USD9,397,136USD5,617,494USD2,886,382USD4,455,375USD
    Net Receivables—3,960,305USD4,506,508USD3,550,895USD13,794,224USD5,227,237USD5,021,057USD3,972,632USD
    Inventory—4,144,179USD6,697,117USD8,618,944USD5,574,253USD6,704,134USD3,647,406USD2,302,030USD
    Accumulated Other Comprehensive Income—-581,519USD-581,519USD-581,519USD-581,519USD-581,519USD-581,519USD-581,519USD
    Unclassified Non Current Assets—11,883,126USD12,707,419USD-1,561,564USD-2,440,944USD———
    Unclassified Current Liabilities—-1,025,837USD—-1,511,095USD-3,237,211USD-25,893,874USD-17,706,649USD-29,780,011USD
    Deferred Long Term Liab———81,067USD63,426USD74,724USD296,605USD932,919USD
    Other Liab———99,644USD78,412USD89,704USD543,759USD962,919USD
    Treasury Stock———-7,806,605USD-7,806,605USD-7,806,605USD-7,806,605USD-7,806,605USD
    Net Tangible Assets———69,982,323USD141,366,202USD17,480,257USD5,285,709USD2,124,757USD
    Accumulated Depreciation———————-3,901,418USD
    Additional Paid In Capital———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-03-31 · USDQ1 20262025-12-31 · USDQ4 20252025-09-30 · USDQ3 20252025-06-30 · USDQ2 20252025-03-31 · USDQ1 20252024-12-31 · USDQ4 20242024-09-30 · USDQ3 20242024-06-30 · USD
    Net Income-3,092,550USD-5,332,579USD1,453,507USD-7,332,820USD-7,901,619USD-8,945,347USD-8,530,623USD-10,968,874USD
    Depreciation28,194USD28,193USD28,573USD29,331USD29,331USD64,870USD65,144USD65,104USD
    Stock Based Compensation402,712USD757,605USD1,534,801USD1,669,428USD2,223,843USD2,674,105USD3,226,879USD3,376,406USD
    Other Non Cash Items-3,394,132USD1,037,970USD-8,671,392USD-304,299USD-794,622USD-1,669,972USD287,728USD493,157USD
    Change To Account Receivables0USD0USD0USD0USD0USD-657,253USD-2,318,242USD1,143,268USD
    Change To Inventory0USD0USD0USD0USD0USD863,928USD497,404USD-624,749USD
    Change In Working Capital-2,456,437USD-1,874,881USD163,175USD456,058USD-1,293,396USD-3,454,728USD445,527USD1,231,959USD
    Total Cash From Operating Activities-8,914,925USD-6,169,490USD-5,491,336USD-5,482,302USD-7,736,463USD-11,332,987USD-4,366,094USD-5,645,809USD
    Capital Expenditures-5USD0USD-4USD0USD0USD-1,083USD-63,036USD-54,630USD
    Free Cash Flow-8,914,920USD-6,169,490USD-5,491,336USD-5,482,302USD-7,736,463USD-11,334,070USD-4,429,130USD-5,700,439USD
    Investments3,168,910USD0USD0USD474,064USD1,147,853USD17,245,315USD131,500USD55,370USD
    Total Cashflows From Investing Activities3,520,328USD—6,275,744USD474,064USD1,147,853USD17,245,315USD131,500USD55,370USD
    Total Cash From Financing Activities0USD23,366,345USD23,366,345USD0USD0USD-4,221,611USD0USD3,280USD
    Issuance Of Capital Stock0USD23,366,345USD0USD0USD0USD0USD0USD0USD
    Change In Cash-5,394,597USD17,196,855USD784,408USD-5,008,238USD-6,588,610USD1,690,717USD-4,234,594USD-5,587,159USD
    Begin Period Cash Flow32,991,417USD15,794,562USD15,010,154USD20,018,392USD26,607,000USD24,916,285USD29,150,879USD34,738,038USD
    End Period Cash Flow27,596,820USD32,991,417USD15,794,562USD15,010,154USD20,018,392USD26,607,000USD24,916,285USD29,150,879USD
    Other Cashflows From Investing Activities3,520,328USD——16,632,029USD1,147,853USD16,853,181USD194,536USD110,000USD
    Unclassified Investing Cash Flow-3,168,905USD—6,275,748USD-16,632,029USD-1,147,853USD-16,852,098USD——
    Other Cashflows From Financing Activities—23,366,345USD-4,221,611USD——-4,221,611USD35,295,115USD3,280USD
    Unclassified Financing Cash Flow—-23,366,345USD27,587,956USD———-35,295,115USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-09-30 · USDFY 20242024-09-30 · USDFY 20232023-09-30 · USDFY 20222022-09-30 · USDFY 20212021-09-30 · USDFY 20202020-09-30 · USDFY 20192019-09-30 · USDFY 20182018-09-30 · USD
    Net Income-22,726,279USD-37,801,426USD-93,152,692USD-83,776,020USD7,394,374USD-18,973,535USD-12,017,366USD-23,938,389USD
    Depreciation152,105USD268,177USD269,874USD209,595USD211,394USD462,741USD471,421USD452,048USD
    Stock Based Compensation8,102,177USD13,644,405USD17,918,603USD11,242,423USD5,050,389USD2,646,246USD1,906,098USD1,638,505USD
    Other Non Cash Items-11,440,284USD1,616,836USD1,924,360USD-1,139,171USD-17,375,575USD19,535,741USD6,156,753USD6,132,119USD
    Change To Account Receivables-657,253USD546,203USD-4,153,327USD4,537,829USD-3,561,987USD-87,790USD-1,351,709USD1,874,555USD
    Change To Inventory863,928USD986,108USD648,628USD-3,126,710USD546,378USD-3,301,551USD-1,454,483USD375,038USD
    Change In Working Capital-4,128,891USD222,493USD-15,151,458USD25,881,963USD-7,282,558USD-4,346,276USD-1,564,049USD3,539,376USD
    Total Cash From Operating Activities-30,043,088USD-21,682,333USD-88,013,814USD-47,505,004USD-15,571,024USD-1,930,095USD-5,485,207USD-11,546,191USD
    Capital Expenditures-1,083USD-158,322USD-665,700USD-733,052USD-376,649USD-105,760USD-108,517USD-50,654USD
    Free Cash Flow-30,044,171USD-21,840,655USD-88,679,514USD-48,238,056USD-15,947,673USD-2,035,855USD-5,593,724USD-11,596,845USD
    Investments393,217USD146,214USD6,334,300USD4,266,948USD14,623,351USD-105,760USD-108,517USD-50,654USD
    Total Cashflows From Investing Activities25,142,976USD146,214USD6,334,300USD4,266,948USD14,623,351USD-105,760USD-108,517USD-50,654USD
    Total Cash From Financing Activities-4,221,611USD36,826,910USD11,114,333USD1,069,196USD109,718,430USD9,329,481USD8,129,367USD12,078,752USD
    Issuance Of Capital Stock0USD35,295,115USD6,009,366USD0USD108,099,988USD108,099,988USD9,400,000USD3,000,000USD
    Change In Cash-9,121,723USD15,290,791USD-70,565,181USD-42,168,860USD108,770,757USD7,293,626USD2,535,643USD481,907USD
    Begin Period Cash Flow24,916,285USD9,625,494USD80,190,675USD122,359,535USD13,588,778USD6,295,152USD3,759,509USD3,277,602USD
    End Period Cash Flow15,794,562USD24,916,285USD9,625,494USD80,190,675USD122,359,535USD13,588,778USD6,295,152USD3,759,509USD
    Other Cashflows From Investing Activities24,750,842USD304,536USD7,000,000USD5,000,000USD15,000,000USD-105,760USD-105,760USD-105,760USD
    Other Cashflows From Financing Activities-4,221,611USD1,664,770USD4,971,992USD1,078,289USD1,637,877USD13,765,179USD3,664,967USD2,721,237USD
    Net Borrowings——0USD-9,093USD-19,435USD-4,421,915USD-4,935,600USD9,090,592USD
    Unclassified Investing Cash Flow——-6,334,300USD-4,266,948USD-14,623,351USD———
    Change To Liabilities———27,291,937USD4,845,332USD-1,258,468USD1,946,449USD1,355,353USD
    Sale Purchase Of Stock———1,078,289USD109,737,865USD-50,284USD13,333,000USD-77,840USD
    Cash And Cash Equivalents Changes———-42,168,860USD108,770,757USD7,293,626USD2,535,643USD481,907USD
    Unclassified Financing Cash Flow———-1,078,289USD-1,637,877USD13,851,964USD-3,933,000USD10,410,763USD
    Unclassified Operating Cash Flow————-3,569,048USD-1,255,012USD——
    Dividends Paid—————-13,815,463USD—-10,066,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2024Yearly · 2024-09-30GeographyBR2,760,540USD0001437749-24-037576
    FY 2024Yearly · 2024-09-30GeographyMZ2,172,840USD0001437749-24-037576
    FY 2024Yearly · 2024-09-30GeographyOther Geographical Areas4,696,800USD0001437749-24-037576
    FY 2024Yearly · 2024-09-30GeographyUnited States5,354,090USD0001437749-24-037576
    FY 2024Yearly · 2024-09-30GeographyZA1,902,149USD0001437749-24-037576
    FY 2024Yearly · 2024-09-30ProductFC2Female Condom16,886,419USD0001437749-24-037576
    FY 2024Yearly · 2024-09-30ProductProduct And Service Other0USD0001437749-24-037576
    Q3 2024Quarterly · 2024-06-30GeographyMZ1,317,480USD0001437749-24-025338
    Q3 2024Quarterly · 2024-06-30GeographyOther Geographical Areas1,529,381USD0001437749-24-025338
    Q3 2024Quarterly · 2024-06-30GeographyUnited States1,107,009USD0001437749-24-025338
    Q3 2024Quarterly · 2024-06-30GeographyZA0USD0001437749-24-025338
    Q3 2024Quarterly · 2024-06-30ProductENTADFICapsules0USD0001437749-24-025338
    Q3 2024Quarterly · 2024-06-30ProductFC2Female Condom3,953,870USD0001437749-24-025338
    Q2 2024Quarterly · 2024-03-31GeographyMZ855,360USD0000863894-24-000011
    Q2 2024Quarterly · 2024-03-31GeographyOther Countries865,112USD0000863894-24-000011
    Q2 2024Quarterly · 2024-03-31GeographyUnited States1,237,629USD0000863894-24-000011
    Q2 2024Quarterly · 2024-03-31GeographyZA1,177,200USD0000863894-24-000011
    Q2 2024Quarterly · 2024-03-31ProductFc2Products — Fc2Global Public Health Sector3,537,994USD0000863894-24-000011
    Q2 2024Quarterly · 2024-03-31ProductFc2Products — Fc2U.s.Prescription Channel597,307USD0000863894-24-000011
    Q1 2024Quarterly · 2023-12-31GeographyOther Countries784,637USD0000863894-24-000008
    Q1 2024Quarterly · 2023-12-31GeographyUnited States1,356,089USD0000863894-24-000008
    Q1 2024Quarterly · 2023-12-31ProductFc2Products — Fc2Global Public Health Sector1,507,007USD0000863894-24-000008
    Q1 2024Quarterly · 2023-12-31ProductFc2Products — Fc2U.s.Prescription Channel633,719USD0000863894-24-000008
    FY 2023Yearly · 2023-09-30GeographyOther Geographical Areas5,985,078USD0001437749-24-037576
    FY 2023Yearly · 2023-09-30GeographyUnited States8,370,202USD0001437749-24-037576
    FY 2023Yearly · 2023-09-30GeographyZA1,941,678USD0001437749-24-037576
    FY 2023Yearly · 2023-09-30ProductFc2Products — Fc2Global Public Health Sector10,460,024USD0000863894-23-000017
    FY 2023Yearly · 2023-09-30ProductFc2Products — Fc2U.s.Prescription Channel5,823,921USD0000863894-23-000017
    FY 2023Yearly · 2023-09-30ProductOther Products13,013USD0000863894-23-000017
    Q4 2023Quarterly · 2023-09-30ProductFc2Products — Fc2Global Public Health Sector3,210,709USDLegacy provider
    Q4 2023Quarterly · 2023-09-30ProductFc2Products — Fc2U.s.Prescription Channel651,378USDLegacy provider
    Q4 2023Quarterly · 2023-09-30ProductOther Products0USDLegacy provider
    Q3 2023Quarterly · 2023-06-30GeographyOther Geographical Areas1,279,302USD0001437749-24-025338
    Q3 2023Quarterly · 2023-06-30GeographyUnited States1,449,883USD0001437749-24-025338
    Q3 2023Quarterly · 2023-06-30GeographyZA612,000USD0001437749-24-025338
    Q3 2023Quarterly · 2023-06-30ProductFc2Products — Fc2Global Public Health Sector2,478,031USD0000863894-23-000009
    Q3 2023Quarterly · 2023-06-30ProductFc2Products — Fc2U.s.Prescription Channel863,379USD0000863894-23-000009
    Q3 2023Quarterly · 2023-06-30ProductOther Products-225USD0000863894-23-000009
    Q2 2023Quarterly · 2023-03-31GeographyOther Countries470,309USD0000863894-24-000011
    Q2 2023Quarterly · 2023-03-31GeographyUnited States4,787,258USD0000863894-24-000011
    Q2 2023Quarterly · 2023-03-31GeographyZA1,328,400USD0000863894-24-000011
    Q2 2023Quarterly · 2023-03-31ProductEntadfi5,520USD0000863894-24-000011
    Q2 2023Quarterly · 2023-03-31ProductFc2Products — Fc2Global Public Health Sector2,434,287USD0000863894-24-000011
    Q2 2023Quarterly · 2023-03-31ProductFc2Products — Fc2U.s.Prescription Channel4,146,160USD0000863894-24-000011
    Q1 2023Quarterly · 2022-12-31GeographyOther Countries1,440,948USD0000863894-24-000008
    Q1 2023Quarterly · 2022-12-31GeographyUG257,469USD0000863894-24-000008
    Q1 2023Quarterly · 2022-12-31GeographyUnited States809,377USD0000863894-24-000008
    Q1 2023Quarterly · 2022-12-31ProductEntadfi7,793USD0000863894-24-000008
    Q1 2023Quarterly · 2022-12-31ProductFc2Products — Fc2Global Public Health Sector2,336,997USD0000863894-24-000008
    Q1 2023Quarterly · 2022-12-31ProductFc2Products — Fc2U.s.Prescription Channel163,004USD0000863894-24-000008
    FY 2022Yearly · 2022-09-30GeographyOther Countries7,924,117USD0000863894-23-000017
    FY 2022Yearly · 2022-09-30GeographyUnited States31,430,235USD0000863894-23-000017
    FY 2022Yearly · 2022-09-30ProductFc2Products — Fc2Global Public Health Sector9,128,858USD0000863894-23-000017
    FY 2022Yearly · 2022-09-30ProductFc2Products — Fc2U.s.Prescription Channel30,223,079USD0000863894-23-000017
    FY 2022Yearly · 2022-09-30ProductOther Products2,415USD0000863894-23-000017
    Q4 2022Quarterly · 2022-09-30GeographyOther Countries1,938,667USDLegacy provider
    Q4 2022Quarterly · 2022-09-30GeographyUnited States649,964USDLegacy provider
    Q4 2022Quarterly · 2022-09-30ProductFc2Products — Fc2Global Public Health Sector2,264,027USDLegacy provider
    Q4 2022Quarterly · 2022-09-30ProductFc2Products — Fc2U.s.Prescription Channel322,189USDLegacy provider
    Q3 2022Quarterly · 2022-06-30GeographyOther Countries2,577,409USD0000863894-23-000009
    Q3 2022Quarterly · 2022-06-30GeographyUnited States7,024,786USD0000863894-23-000009
    FY 2021Yearly · 2021-09-30GeographyOther Countries12,320,707USD0000863894-22-000017
    FY 2021Yearly · 2021-09-30GeographyUnited States48,938,821USD0000863894-22-000017
    FY 2021Yearly · 2021-09-30ProductFc2Products — Fc2Global Public Health Sector13,926,249USD0000863894-22-000017
    FY 2021Yearly · 2021-09-30ProductFc2Products — Fc2U.s.Prescription Channel46,470,448USD0000863894-22-000017
    FY 2021Yearly · 2021-09-30ProductOther Products862,831USD0000863894-22-000017
    FY 2021Yearly · 2021-09-30SegmentFc260,396,697USD0000863894-21-000013
    FY 2021Yearly · 2021-09-30SegmentPreboost862,831USD0000863894-21-000013
    Q1 2021Quarterly · 2020-12-31SegmentFc213,754,158USD0000863894-22-000003
    Q1 2021Quarterly · 2020-12-31SegmentPreboost862,831USD0000863894-22-000003
    FY 2020Yearly · 2020-09-30GeographyOther Countries12,253,945USD0000863894-21-000013
    FY 2020Yearly · 2020-09-30GeographyUnited States30,338,115USD0000863894-21-000013
    FY 2020Yearly · 2020-09-30SegmentFc240,556,818USD0000863894-21-000013
    FY 2020Yearly · 2020-09-30SegmentPreboost2,035,242USD0000863894-21-000013
    Q4 2020Quarterly · 2020-09-30SegmentFc210,963,903USDLegacy provider
    Q4 2020Quarterly · 2020-09-30SegmentPreboost785,283USDLegacy provider
    Q3 2020Quarterly · 2020-06-30SegmentFc29,645,720USD0000863894-21-000009
    Q3 2020Quarterly · 2020-06-30SegmentPreboost676,034USD0000863894-21-000009
    Q2 2020Quarterly · 2020-03-31SegmentFc29,522,271USD0000863894-21-000006
    Q2 2020Quarterly · 2020-03-31SegmentPreboost420,833USD0000863894-21-000006
    Q1 2020Quarterly · 2019-12-31SegmentFc210,424,924USD0000863894-21-000003
    Q1 2020Quarterly · 2019-12-31SegmentPreboost153,092USD0000863894-21-000003
    FY 2019Yearly · 2019-09-30GeographyOther Countries14,543,213USD0000863894-20-000021
    FY 2019Yearly · 2019-09-30GeographyUnited States17,260,174USD0000863894-20-000021
    FY 2019Yearly · 2019-09-30SegmentFc230,919,366USD0000863894-20-000021
    FY 2019Yearly · 2019-09-30SegmentPreboost884,021USD0000863894-20-000021
    Q4 2019Quarterly · 2019-09-30SegmentFc28,467,310USDLegacy provider
    Q4 2019Quarterly · 2019-09-30SegmentPreboost261,093USDLegacy provider
    Q3 2019Quarterly · 2019-06-30SegmentFc29,283,736USD0000863894-20-000016
    Q3 2019Quarterly · 2019-06-30SegmentPreboost443,324USD0000863894-20-000016
    Q2 2019Quarterly · 2019-03-31SegmentFc26,843,923USD0000863894-20-000011
    Q2 2019Quarterly · 2019-03-31SegmentPreboost132,192USD0000863894-20-000011
    FY 2018Yearly · 2018-09-30GeographyOther Countries5,523,491USD0000863894-19-000014
    FY 2018Yearly · 2018-09-30GeographyUnited States5,221,052USD0000863894-19-000014
    FY 2018Yearly · 2018-09-30GeographyZA2,960,677USD0000863894-19-000014
    FY 2018Yearly · 2018-09-30GeographyZW2,159,263USD0000863894-19-000014
    FY 2018Yearly · 2018-09-30SegmentFc215,852,584USD0000863894-19-000014
    FY 2018Yearly · 2018-09-30SegmentPreboost11,899USD0000863894-19-000014
    FY 2017Yearly · 2017-09-30GeographyCM891,000USD0001562762-17-000231
    FY 2017Yearly · 2017-09-30GeographyMZ1,430,000USD0001562762-17-000231

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.